Skip to main content
. 2022 May 3;14:881488. doi: 10.3389/fnagi.2022.881488

FIGURE 8.

FIGURE 8

ERADMT gene set as an indicator for assessing adherence to exercise prescription in patients with AD. (A,B) Correlation of APP, CCR1, TNF, ATF3, KLF4, HES4, and MAFB expression in CD14+ and CD16+ monocytes based on the GSE181279 single cell dataset, analyzed using Person method, including NC group (A) and AD group (B), red indicates positive correlation whereas blue indicates negative correlation; (C) Expression correlations of APP, CCR1, TNF, ATF3, KLF4, HES4, and MAFB in monocytes were analyzed using the Person method based on the GSE181279 bulk RNA dataset; (D) Schematic diagram of a neural network model for determining whether to exercise using APP, CCR1, TNF, ATF3, KLF4, HES4, and MAFB; (E) The predictive ability of the ERADMT gene set (APP, CCR1, TNF, ATF3, KLF4, HES4, and MAFB) to separately predict whether to undergo exercise or not; (F) ROC curve indicating that the neural network model can accurately predict patients’ exercise compliance; (G) The position of the ERADMT gene set (APP, CCR1, TNF, ATF3, KLF4, HES4, and MAFB) on the chromosome is indicated by the circle plot.